125/DPI (Estropipate 1.5 mg)
Pill with imprint 125/DPI has been identified as Estropipate 1.5 mg. It is supplied by Watson Pharmaceuticals.
Estropipate is used in the treatment of atrophic vaginitis; hypoestrogenism; oophorectomy; osteoporosis; postmenopausal symptoms and belongs to the drug class estrogens. Not for use in pregnancy. Estropipate 1.5 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 125/DPI
Estropipate
- Imprint
- 125/DPI
- Strength
- 1.5 mg
- Availability
- Prescription only
- Drug Class
- Estrogens
- Pregnancy Category
- X - Not for use in pregnancy
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Watson Pharmaceuticals
- National Drug Code (NDC)
- 00364-2601 (Discontinued)
Related Images for "125/DPI"
More about estropipate
- Side effects
- Drug interactions
- Dosage information
- During pregnancy
- Reviews (7)
- Drug images
- En español
- Drug class: estrogens
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.